Owner Onyx Pharmaceuticals, Inc.

Inventors Laquerre, Sylvie; Omer, Charles A.; Delaney, Amy M.; Shen, Yuqiao

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2003297492

PCT Number PCT/US2003/0410

PCT Pub. Number WO2004/061079

Priority 60/436,707 27.12.02 US

Filing date 23 December 2003

Wipo publication date 29 July 2004

Acceptance publication date 25 October 2007

C12N 15/00 (2006.01) Mutation or genetic engineering

C07H 21/02 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 1/00 (2006.01) General processes for the preparation of peptides

C12N 1/20 (2006.01) Micro-organisms, e.g. protozoa - Bacteria

C12N 5/00 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines

C12N 9/78 (2006.01) Enzymes, e.g. ligases (6.) - acting on carbon to nitrogen bonds other than peptide bonds (3.5)

C12P 21/06 (2006.01) Preparation of peptides or proteins - produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

C12Q 1/34 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving hydrolase